NASDAQ$AVIR

Atea Pharmaceuticals Inc · Q2 2016 earnings

Q2 2016 earnings · · Investor relations

Headline financials

Total Revenue

$1.7M

No prior period
EPS (adj)

-$0.17

No prior period

Revenue & EPS history

Atea · Revenue · Quarterly

$1.7M

Q2 2016
Beat estimate in 3 of 8 quarters(38%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports

Historical avg

+0.1%

Avg return

Earnings day

+0.6%

Avg return

5 days after

+4.2%

Avg return

30 days after

50%

12 / 24 earnings

Positive

+16.1%

Q1 2021

Best reaction

-16.2%

Q2 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025+11.1%+15.1%+8.7%
Q3 2025-12.1%-12.9%-10.0%
Q2 2025-2.6%+1.2%-2.6%
Q1 2025+2.2%+4.0%+16.4%
Q4 2024-0.3%+3.3%-7.0%
Q3 2024-2.2%-7.0%-17.9%
Q1 2024-8.2%-9.7%-8.4%
Q4 2023-5.5%-11.4%-11.4%
Q3 2023-10.7%-14.0%-10.1%
Q2 2023+4.1%+0.3%-3.5%
Q1 2023-1.2%-3.0%+35.8%
Q4 2022-8.7%-0.8%-8.1%
Q3 2022-12.4%-14.4%-24.0%
Q2 2022-3.5%-4.3%-11.7%
Q1 2022+12.9%+36.8%+52.7%
Q4 2021+1.4%-9.7%+11.1%
Q3 2021+6.5%+6.5%-25.3%
Q2 2021-16.2%-12.9%-13.4%
Q1 2021+16.1%+18.7%+20.4%
Q2 2020+5.3%-1.4%-55.0%
Q4 2020+5.3%-1.4%-55.0%
Q1 2020+7.2%+10.6%+73.1%
Q4 2019+7.2%+10.6%+73.1%
Q3 2020+7.2%+10.6%+73.1%
Q3 2019
Q2 2019
Q1 2019
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro